Efficacy and indications of Dolutegravir Sodium

Dolutegravir Sodium is an integrase inhibitor mainly used to treat human immunodeficiency virus (HIV) infection, also known as HIV infection. Its functions and indications are as follows:

1.Antiretroviral efficacy: The main role of dolutegravir sodium in HIV infected patients is to inhibit the replication and spread of the virus. It inhibits the virus from integrating its genetic material into the host cell genome by blocking the activity of HIV integrase, thus blocking the replication process of the virus. By reducing the number of viruses, dolutegravir sodium can effectively reduce the viral load, control the progression of the disease, and improve the patient's immune function.

2.Antiretroviral therapy: Dolutegravir sodium is usually used as part of an antiretroviral therapy (Antiretroviral Therapy, ART) regimen, in combination with other antiretroviral drugs (such as nucleotide reverse transcriptase inhibitors and non-nucleotide reverse transcriptase inhibitors). This combination treatment can more effectively inhibit the replication of HIV, reduce the viral load, slow down the progression of the disease, improve the patient's quality of life, and extend the patient's lifespan.

3.Delay the progression of AIDS: The use of dolutegravir sodium helps reduce the viral load and maintain the immune function of AIDS patients, thereby delaying the progression of the disease. It can reduce the damage caused by HIV to the immune system, reduce the occurrence of AIDS-related complications, and enable patients to maintain better health.

4. Improve quality of life: By effectively controlling viral replication and reducing viral load, dolutegravir sodium helps improve patients' physical condition and immune function. This can reduce the occurrence of HIV-related symptoms and complications, improve patients' quality of life, and enable them to better cope with daily life and work.

It should be noted that dolutegravir sodium cannot completely cureHIV infection, but it can significantly slow down the progression of the disease and improve the patient's quality of life. Treatment plans should be individually formulated based on the patient's specific situation and the virus's drug resistance, and should be conducted under the guidance of professional doctors. In addition, preventionHIVInfection remains critical, including practicing safe sex and using condoms.

Dolutegravir sodium has been launched in China, but it has not yet been included in medical insurance. Patients can purchase it in hospital pharmacies at a price of around 1,200 yuan. Please consult the local hospital pharmacy for specific prices. Dolutegravir sodium is cheaper abroad, mainly Indian generic drugs, with a price of around 350 yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.